- Home
- TCRX vs PLBY Comparison
TCRX vs PLBY Comparison
Compare TCRX & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- PLBY
- Stock Information
- Founded
- TCRX 2018
- PLBY 1953
- Country
- TCRX United States
- PLBY United States
- Employees
- TCRX N/A
- PLBY N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- PLBY Recreational Games/Products/Toys
- Sector
- TCRX Health Care
- PLBY Consumer Discretionary
- Exchange
- TCRX Nasdaq
- PLBY Nasdaq
- Market Cap
- TCRX 98.5M
- PLBY 113.4M
- IPO Year
- TCRX 2021
- PLBY N/A
- Fundamental
- Price
- TCRX $1.38
- PLBY $1.10
- Analyst Decision
- TCRX Strong Buy
- PLBY Buy
- Analyst Count
- TCRX 6
- PLBY 2
- Target Price
- TCRX $9.83
- PLBY $2.35
- AVG Volume (30 Days)
- TCRX 442.7K
- PLBY 678.0K
- Earning Date
- TCRX 03-05-2025
- PLBY 03-13-2025
- Dividend Yield
- TCRX N/A
- PLBY N/A
- EPS Growth
- TCRX N/A
- PLBY N/A
- EPS
- TCRX N/A
- PLBY N/A
- Revenue
- TCRX $2,816,000.00
- PLBY $116,135,000.00
- Revenue This Year
- TCRX $32.21
- PLBY N/A
- Revenue Next Year
- TCRX $118.35
- PLBY $3.28
- P/E Ratio
- TCRX N/A
- PLBY N/A
- Revenue Growth
- TCRX N/A
- PLBY N/A
- 52 Week Low
- TCRX $1.28
- PLBY $0.52
- 52 Week High
- TCRX $9.69
- PLBY $2.44
- Technical
- Relative Strength Index (RSI)
- TCRX 31.10
- PLBY 35.52
- Support Level
- TCRX $1.44
- PLBY $1.05
- Resistance Level
- TCRX $1.76
- PLBY $1.16
- Average True Range (ATR)
- TCRX 0.17
- PLBY 0.12
- MACD
- TCRX -0.01
- PLBY 0.01
- Stochastic Oscillator
- TCRX 16.39
- PLBY 22.46
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.